Does DORIPENEM Cause Thrombotic microangiopathy? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Thrombotic microangiopathy have been filed in association with DORIPENEM. This represents 2.1% of all adverse event reports for DORIPENEM.
5
Reports of Thrombotic microangiopathy with DORIPENEM
2.1%
of all DORIPENEM reports
0
Deaths
5
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From DORIPENEM?
Of the 5 reports, 5 (100.0%) required hospitalization, and 5 (100.0%) were considered life-threatening.
Is Thrombotic microangiopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DORIPENEM. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does DORIPENEM Cause?
Hepatic function abnormal (28)
Pyrexia (28)
Diarrhoea (25)
Sepsis (20)
Drug ineffective (17)
Liver disorder (16)
Pneumonia (15)
Drug resistance (12)
Renal impairment (12)
Febrile neutropenia (10)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)
Which DORIPENEM Alternatives Have Lower Thrombotic microangiopathy Risk?
DORIPENEM vs DORNASE ALFA
DORIPENEM vs DORZOLAMIDE
DORIPENEM vs DORZOLAMIDE\TIMOLOL
DORIPENEM vs DOSTARLIMAB
DORIPENEM vs DOSTARLIMAB-GXLY